Previous Close | 20.23 |
Open | 20.41 |
Bid | 20.30 x 900 |
Ask | 20.66 x 1100 |
Day's Range | 20.30 - 20.75 |
52 Week Range | 10.84 - 24.08 |
Volume | |
Avg. Volume | 2,397,312 |
Market Cap | 5.251B |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | 5.00 |
EPS (TTM) | 4.08 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | 1.12 (5.46%) |
Ex-Dividend Date | May 10, 2024 |
1y Target Est | 22.25 |
JERSEY CITY, N.J., May 08, 2024--Organon (NYSE: OGN) ("Organon"), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the "Co-Issuer" and, together with Organon, the "Companies"), have priced an offering of $500 million of 6.750% senior secured notes due 2034 (the "Secured Notes") and $500 million of 7.875% senior unsecured notes due 2034 (the "Unsecured
JERSEY CITY, N.J., May 07, 2024--Organon (NYSE: OGN) ("Organon"), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the "Co-Issuer" and, together with Organon, the "Companies"), plan to offer, subject to market conditions, $500 million of senior secured notes due 2034 (the "secured notes") and $500 million of senior unsecured notes due 2034 (the "unsecu
The board of Organon & Co. ( NYSE:OGN ) has announced that it will pay a dividend on the 13th of June, with investors...